TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

PURPOSE: We previously reported a dose-finding and phase II trial of the TI-CE regimen (paclitaxel [T] plus ifosfamide [I] followed by high-dose carboplatin [C] plus etoposide [E] with stem-cell support) in germ cell tumor (GCT) patients predicted to have a poor prognosis with conventional-dose salv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Feldman, Darren R., Sheinfeld, Joel, Bajorin, Dean F., Fischer, Patricia, Turkula, Stefan, Ishill, Nicole, Patil, Sujata, Bains, Manjit, Reich, Lilian M., Bosl, George J., Motzer, Robert J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2010
Schlagworte:
Original Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651604/
https://ncbi.nlm.nih.gov/pubmed/20194867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.1561
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge